100% Quality Guarantee
PhD-Level Technical Support
Rat Tubulointerstitial Nephritis Antigen-Like TINAGL1 ELISA Kit
Key Features

Rat Tubulointerstitial Nephritis Antigen-Like (TINAGL1) ELISA Kit (RTDL01032)

SKU RTDL01032
Product Type ELISA Kit
Sensitivity 32.6pg/mL
Range 78.1-5000pg/mL
ELISA Type Sandwich
Synonyms Glucocorticoid-inducible protein 5
Reactivity Rat
Sample Type Serum, Plasma, Tissue Homogenates And Other Biological Fluids
€862

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

Rat Tubulointerstitial Nephritis Antigen-Like (TINAGL1) ELISA Kit

The Rat Tubulointerstitial Nephritis Antigen-like (TINAGL1) ELISA Kit is specifically designed for the accurate measurement of TINAGL1 levels in rat serum, plasma, and cell culture supernatants. This kit offers high sensitivity and specificity, ensuring precise and consistent results, making it an indispensable tool for various research applications.TINAGL1 is a key protein involved in tubulointerstitial nephritis, playing a crucial role in the pathogenesis and progression of kidney diseases.

By quantifying TINAGL1 levels, researchers can gain valuable insights into the mechanisms underlying these conditions and potentially identify new therapeutic targets.Overall, the Rat TINAGL1 ELISA Kit offers researchers a reliable method for studying tubulointerstitial nephritis and related kidney disorders, leading to a better understanding of these diseases and the development of effective treatment strategies.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose